Schneiderman Daniel H has filed 7 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 1129323 shares of Pasithea Therapeutics Corp. ($KTTA) on May 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 1129323 | $0.00 | 1,129,323.0000 | 7,031,050 | 9999.99% | 16.06% |
| Nov. 28, 2025 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Common Stock | 26667 | $0.75 | 26,667.0000 | 7,443,577 | 9999.99% | 0.36% |
| Oct. 24, 2025 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 317266 | $0.00 | 317,266.0000 | 7,443,577 | 9999.99% | 4.26% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 5927 | $0.00 | 5,927.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 1,226,600 | 9999.99% | 0.82% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 5927 | $0.00 | 5,927.0000 | 1,226,600 | 9999.99% | 0.48% |
| March 1, 2024 | Pasithea Therapeutics Corp. | $KTTA | Schneiderman Daniel H | Chief Financial Officer | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 1,226,600 | 9999.99% | 0.82% |